DAURIZ, Marco
 Distribuzione geografica
Continente #
NA - Nord America 4.195
EU - Europa 3.851
AS - Asia 2.869
SA - Sud America 470
Continente sconosciuto - Info sul continente non disponibili 164
AF - Africa 127
OC - Oceania 40
Totale 11.716
Nazione #
US - Stati Uniti d'America 4.052
RU - Federazione Russa 1.225
GB - Regno Unito 1.086
SG - Singapore 913
CN - Cina 778
IT - Italia 464
BR - Brasile 367
VN - Vietnam 284
DE - Germania 205
SE - Svezia 182
HK - Hong Kong 177
IE - Irlanda 160
FR - Francia 159
IN - India 159
FI - Finlandia 139
KR - Corea 120
CA - Canada 73
ID - Indonesia 60
TR - Turchia 60
BD - Bangladesh 57
UA - Ucraina 55
PH - Filippine 40
PK - Pakistan 38
JP - Giappone 36
NL - Olanda 34
ZA - Sudafrica 34
AR - Argentina 30
AU - Australia 30
IR - Iran 30
ES - Italia 25
MX - Messico 23
BE - Belgio 22
EG - Egitto 22
EC - Ecuador 21
PL - Polonia 21
IQ - Iraq 19
AT - Austria 14
CR - Costa Rica 14
VE - Venezuela 14
CO - Colombia 13
GR - Grecia 13
NG - Nigeria 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
IL - Israele 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
CY - Cipro 7
ET - Etiopia 7
GH - Ghana 7
LY - Libia 7
PY - Paraguay 7
GE - Georgia 6
JM - Giamaica 6
KE - Kenya 6
MY - Malesia 6
SV - El Salvador 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CL - Cile 5
LV - Lettonia 5
PT - Portogallo 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
CH - Svizzera 4
CW - ???statistics.table.value.countryCode.CW??? 4
GT - Guatemala 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
PE - Perù 4
TG - Togo 4
TJ - Tagikistan 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
JO - Giordania 3
NI - Nicaragua 3
PR - Porto Rico 3
RO - Romania 3
SC - Seychelles 3
BA - Bosnia-Erzegovina 2
BJ - Benin 2
BO - Bolivia 2
EU - Europa 2
GP - Guadalupe 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NP - Nepal 2
QA - Qatar 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A1 - Anonimo 1
AO - Angola 1
BB - Barbados 1
Totale 11.540
Città #
Southend 983
Ashburn 559
Singapore 462
Moscow 451
Chandler 396
Dallas 390
San Jose 364
Verona 197
Hong Kong 174
Dublin 159
Beijing 147
Ann Arbor 138
Jacksonville 135
New York 130
Woodbridge 129
Council Bluffs 109
Houston 88
The Dalles 82
Ho Chi Minh City 80
Los Angeles 75
Lawrence 61
Princeton 61
Wilmington 60
Jinan 51
Munich 50
Hanoi 49
Helsinki 48
Dong Ket 47
Nanjing 44
Santa Clara 44
Shenyang 44
São Paulo 40
Buffalo 34
Frankfurt am Main 33
Jakarta 33
Seoul 33
Tokyo 32
Turku 32
Tianjin 29
Hebei 28
Milan 25
Kolkata 24
Columbus 22
Ankara 21
Orem 21
Redondo Beach 21
Toronto 21
Zhengzhou 21
Johannesburg 20
Nanchang 19
Changsha 18
Brussels 17
Guangzhou 16
Haikou 16
Hyderabad 16
Mumbai 16
Albany 15
Amsterdam 15
Chicago 15
Denver 15
London 15
Seattle 15
Taizhou 15
Warsaw 15
Atlanta 14
Bologna 14
Redmond 14
Abuja 13
Brooklyn 13
Hangzhou 13
Kent 13
Montreal 13
Ningbo 13
San Francisco 13
Semarang 13
Sindelfingen 13
Boardman 12
Boston 12
Chennai 12
Shanghai 12
Tashkent 12
Belo Horizonte 11
Haiphong 11
Istanbul 11
San José 11
Vienna 11
Washington 11
Jiaxing 10
Mersin 10
Nikaia 10
Phoenix 10
Redwood City 10
Rio de Janeiro 10
Sydney 10
Cagliari 9
Catanzaro 9
Curitiba 9
Delhi 9
Fuzhou 9
Lancaster 9
Totale 6.944
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 795
Current treatment for Polycystic Ovary Syndrome: focus on adolescence 649
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease. 279
GENETIC DETERMINANTS OF TYPE 2 DIABETES AND ASSOCIATED CARDIOMETABOLIC DISORDERS / DETERMINANTI GENETICI DI DIABETE MELLITO DI TIPO 2 E FENOTIPI CARDIOMETABOLICI ASSOCIATI 275
American Diabetes Association - 75th Scientific Meeting; Section: Epidemiology/Genetics; Poster n. 1788-P: "A Genetic Risk Score of 96 Variants Linked with Type 2 Diabetes and Cardiometabolic Risk Traits Is Associated with Cardiovascular Mortality in 29-Years Follow-up of the Framingham Heart Study (FHS)" 264
A Case Report of Insulinoma Relapse on Background Nesidioblastosis: A Rare Cause of Adult Hypoglycemia 263
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 244
A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy 227
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 226
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 225
American Diabetes Association - 75th Scientific Meeting; Section: Epidemiology/Genetics; Poster n. 1581-P: "Nonalcoholic Fatty Liver Disease Is Associated with Heart Valve Calcification in Type 2 Diabetes" 218
Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. 213
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 210
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 209
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 207
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 206
Evolocumab and lipoprotein apheresis combination therapy may have synergic effects to reduce low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemia: A case report 198
Effects of Aerobic and Resistance Training on Circulating micro-RNA Expression Profile in Subjects with Type 2 Diabetes 198
Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents 197
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 190
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 190
Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry 187
Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population 187
Psychological distress, Self-Efficacy and Glycemic Control in Type 2 Diabetes 183
Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysis 183
Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study 182
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 180
A closed-loop multi-level model of glucose homeostasis 179
Association between nonalcoholic fatty liver disease and colorectal Tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis 174
Assessment of simple strategies for identifying undiagnosed diabetes and prediabetes in the general population 171
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 168
Association of the IGF1 gene with fasting insulin levels 168
Sex differences in the association of psychological status with measures of physical activity and sedentary behaviour in adults with type 2 diabetes 167
Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications.: A position statement of the Italian Society of Diabetology 164
Association of levels of fasting glucose and insulin with rare variants at the chromosome 11p11.2-MADD locus: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study. 158
GENETIC DETERMINANTS OF TYPE 2 DIABETES AND ASSOCIATED CARDIOMETABOLIC DISORDERS / DETERMINANTI GENETICI DI DIABETE MELLITO DI TIPO 2 E FENOTIPI CARDIOMETABOLICI ASSOCIATI 158
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. 157
Diabetes mellitus in stroke unit: prevalence and outcomes-the Verona acute coronary syndrome and stroke in diabetes outcome (VASD-OUTCOME) study 156
Trans-ethnic Meta-Analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin 153
The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies 152
Letter: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density-authors' reply 149
Current Insights into the Joint Genetic Basis of Type 2 Diabetes and Coronary Heart Disease. Curr Cardiovasc Risk Rep. 2014 Jan 1;8(1):368. 148
Systematic review and meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density 141
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 134
SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice 134
Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis 132
Mortality from infectious diseases in diabetes 126
Probiotic Soy Milk: A Call to Action 123
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 121
Prognostic impact of in-hospital hyperglycemia in hospitalized patients with acute heart failure: Results of the IN-HF (Italian Network on Heart Failure) Outcome registry 120
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 119
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 119
Polygenic type 2 diabetes prediction at the limit of common variant detection. 112
Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. 112
Serum HMGB1 levels are independently associated with glucose clamp-derived measures of insulin resistance in women with PCOS 111
Metabolic Syndrome and Uric Acid Nephrolithiasis: Insulin Resistance in Focus 109
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial 107
Response to comment on Vassy et al. polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014;63:2172-2182. 106
The power of numbers 106
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA heart failure long-term registry 106
Response to Comment on Olioso D. et al. "Effect of Aerobic and Resistance Training on Circulating Micro-RNA Expression Profile in Subjects with Type 2 Diabetes. J Clin Endocrinol Metab 2019; 104(4):1119-1130" by Chirumbolo S 106
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. 105
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 88
Fifteen-Year Trends of Cardiogenic Shock and Mortality in Patients with Diabetes and Acute Coronary Syndromes 72
Totale 11.716
Categoria #
all - tutte 36.995
article - articoli 31.012
book - libri 462
conference - conferenze 4.891
curatela - curatele 0
other - altro 630
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022252 0 0 0 0 14 33 7 26 20 13 23 116
2022/20231.020 75 120 81 181 88 243 22 67 95 5 26 17
2023/2024730 18 31 60 58 52 83 13 34 33 129 139 80
2024/20251.769 101 119 104 308 106 75 125 87 259 88 134 263
2025/20264.341 289 234 417 653 1.088 262 401 280 241 293 89 94
2026/2027882 86 93 143 549 11 0 0 0 0 0 0 0
Totale 11.716